SOLVENTUM CORPORATION Financing Cash Flow
SOLVENTUM CORPORATION (SOLV) reported Financing Cash Flow of -$350.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- SOLVENTUM CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$300.00M.
- SOLVENTUM CORPORATION net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$50.00M.
- SOLVENTUM CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$115.00M.
- SOLVENTUM CORPORATION net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$2.69B.
- SOLVENTUM CORPORATION net cash provided by (used in) financing activities for fiscal 2025 was -$3.06B.
- SOLVENTUM CORPORATION net cash provided by (used in) financing activities for fiscal 2024 was -$240.00M.
- SOLVENTUM CORPORATION net cash provided by (used in) financing activities for fiscal 2023 was -$1.55B.
- SOLVENTUM CORPORATION net cash provided by (used in) financing activities for fiscal 2022 was -$1.46B.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$300.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$350.00M 10-Q · filed 2026-08-05 | -$465.00M derived: sum of 3 quarters · filed 2026-08-05 | -$3.16B derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$50.00M 10-Q · filed 2026-05-05 | -$165.00M derived: sum of 2 quarters · filed 2026-05-05 | -$2.86B derived: sum of 3 quarters · filed 2026-05-05 | -$2.97B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$115.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$2.81B derived: sum of 2 quarters · filed 2026-02-27 | -$2.92B derived: sum of 3 quarters · filed 2026-08-05 | -$3.06B 10-K · filed 2026-02-27 |
| 2025-09-30 | -$2.69B derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$2.80B derived: sum of 2 quarters · filed 2026-08-05 | -$2.94B 10-Q · filed 2025-11-06 | -$3.05B derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$110.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$249.00M 10-Q · filed 2026-08-05 | -$353.00M derived: sum of 3 quarters · filed 2026-08-05 | -$555.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$139.00M 10-Q · filed 2026-05-05 | -$243.00M derived: sum of 2 quarters · filed 2026-05-05 | -$445.00M derived: sum of 3 quarters · filed 2026-05-05 | -$841.00M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | -$104.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$306.00M derived: sum of 2 quarters · filed 2026-02-27 | -$702.00M derived: sum of 3 quarters · filed 2026-02-27 | -$240.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$202.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$598.00M derived: sum of 2 quarters · filed 2025-11-06 | -$136.00M 10-Q · filed 2025-11-06 | -$442.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$396.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $66.00M 10-Q · filed 2025-08-08 | -$240.00M derived: sum of 3 quarters · filed 2026-02-27 | -$725.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $462.00M 10-Q · filed 2025-05-09 | $156.00M derived: sum of 2 quarters · filed 2026-02-27 | -$329.00M derived: sum of 3 quarters · filed 2026-02-27 | -$628.00M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$306.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$791.00M derived: sum of 2 quarters · filed 2026-02-27 | -$1.09B derived: sum of 3 quarters · filed 2026-02-27 | -$1.55B 10-K · filed 2026-02-27 |
| 2023-09-30 | -$485.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$784.00M derived: sum of 2 quarters · filed 2024-11-08 | -$1.25B 10-Q · filed 2024-11-08 | |
| 2023-06-30 | -$299.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$761.00M 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | -$462.00M 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | -$1.46B 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |